Back to Search Start Over

902: UTILITY OF APIXABAN OR RIVAROXABAN ANTI-XA LEVELS IN TRANSITIONING PATIENTS TO HEPARIN INFUSIONS.

Authors :
Huang, Wan-Ting
Nguyen, Kevin
Patel, Aakash
Lerner, Dmitri
Source :
Critical Care Medicine. 2022 Supplement, Vol. 50, p447-447. 1p.
Publication Year :
2022

Abstract

B Introduction/Hypothesis: b Activated partial thromboplastin times and heparin-calibrated anti-Xa levels are used to monitor unfractionated heparin infusions. B Results: b Fifty-nine patients were included in each study group with similar baseline characteristics, except for the higher utilization of an increased bleeding risk heparin infusion protocol in the evaluation group (23.7% vs 6.8%; p=0.01). [Extracted from the article]

Subjects

Subjects :
*HEPARIN
*APIXABAN
*RIVAROXABAN

Details

Language :
English
ISSN :
00903493
Volume :
50
Database :
Academic Search Index
Journal :
Critical Care Medicine
Publication Type :
Academic Journal
Accession number :
154197607
Full Text :
https://doi.org/10.1097/01.ccm.0000809932.66896.2e